ARCHIVES

No Difference in Toxicity Between IMRT and PRT In Medicare Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Advises Five-Year Limit On Tamoxifen Use, in Letter To Doctors

December 8, 1995

DRCCA Bard Group Recommends No New Nationwide Screening Program Until More Research Is Done

November 5, 1982

NCI Largely Unaffected By NIH Translational Research Center

February 11, 2011

Poverty Play Key Role In Excess Cancer Deaths Among Minorities, President’s Cancer Panel Hears

July 26, 1991

LeMaistre Succeeds Lee Clark As Head Of U. Texas Center

March 10, 1978

ACS Survey Finds Need for Cancer Education Among Hispanic Americans

August 2, 1985